Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors Journal Article


Authors: Kim, J.; Mouw, K. W.; Polak, P.; Braunstein, L. Z.; Kamburov, A.; Tiao, G.; Kwiatkowski, D. J.; Rosenberg, J. E.; Van Allen, E. M.; D'Andrea, A. D.; Getz, G.
Article Title: Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors
Abstract: Alterations in DNA repair pathways are common in tumors and can result in characteristic mutational signatures; however, a specific mutational signature associated with somatic alterations in the nucleotide-excision repair (NER) pathway has not yet been identified. Here we examine the mutational processes operating in urothelial cancer, a tumor type in which the core NER gene ERCC2 is significantly mutated. Analysis of three independent urothelial tumor cohorts demonstrates a strong association between somatic ERCC2 mutations and the activity of a mutational signature characterized by a broad spectrum of base changes. In addition, we note an association between the activity of this signature and smoking that is independent of ERCC2 mutation status, providing genomic evidence of tobacco-related mutagenesis in urothelial cancer. Together, these analyses identify an NER-related mutational signature and highlight the related roles of DNA damage and subsequent DNA repair in shaping tumor mutational landscape.
Keywords: chemotherapy; smoking; transcription; damage; invasive bladder-cancer; urinary-bladder; chronic lymphocytic-leukemia; aristolochic acid; cisplatin-based; dna-repair genes; whole-genome
Journal Title: Nature Genetics
Volume: 48
Issue: 6
ISSN: 1061-4036
Publisher: Nature Publishing Group  
Date Published: 2016-06-01
Start Page: 600
End Page: 606
Language: English
ACCESSION: WOS:000376744200006
DOI: 10.1038/ng.3557
PROVIDER: wos
PMCID: PMC4936490
PUBMED: 27111033
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jonathan Eric Rosenberg
    510 Rosenberg